Cereno Scientific has reported initial long-term safety findings from a [...]

City St George’s, University of London has partnered with Paradigm [...]

A new global initiative aims to address long-standing limitations in [...]

Efzimfotase alfa has shown positive Phase 3 results in children [...]

BridgeBio Pharma has submitted a New Drug Application (NDA) to [...]

Chiesi Global Rare Diseases has received a positive CHMP opinion [...]

Levicept has reported Phase 2 clinical trial results for LEVI-04 [...]

The US Food and Drug Administration (FDA) has reaffirmed that [...]

Tozorakimab has met its primary endpoint in two replicate Phase [...]

FoRx Therapeutics presents preclinical data on FORX-428, a PARG inhibitor [...]